Directly relevant to AD, Wu et al. recently reported that hepatic Ephx2 ablation reduces cerebral Aβ pathology and improves cognition, potentially through circulating EETs capable of crossing the blood-brain barrier [25]. This evidence concerns the gene EPHX2 and Alzheimer disease.